chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Started feeling clammy; slight chills; Mild fever; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: FA7485) via an unspecified route of administration in the arm left on 26Jul2021 at 17:30 (at the age of 35-year-old) as a single dose for COVID-19 immunisation. The medical history included COVID-19. The patient had no known allergies. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any medications within two weeks of vaccination. On 27Jul2021 at 14:00, the patient started feeling clammy, slight chills and mild fever. The patient did not receive any treatment for the reported events. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events started feeling clammy, slight chills and mild fever was recovering at the time of this report.
Administer expired vaccine to patients, after the manufacture date of expiration; This spontaneous case was reported by a health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administer expired vaccine to patients, after the manufacture date of expiration) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048C21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 11-Nov-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administer expired vaccine to patients, after the manufacture date of expiration). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administer expired vaccine to patients, after the manufacture date of expiration) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. Vial did not undergo temperature excursion. Total of 168 doses were given from LOT 048C21A. Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 08-Jun-2022: Live non significant follow up. No new clinically significant information received.
This spontaneous report as received from a nurse refers to roughly 20 unspecified patients of unknown age. On an unknown date, roughly 20 unspecified were vaccinated with VARIVAX (merck) Injection, (strength, dose, frequency, route of administration and indication were not provided) that reached 18.5 F for 10 hours and 44 minutes. This range was outside of storage conditions in product insert; however, in house stability data can support those conditions mentioned above that the VARIVAX (merck) was exposed to. No concomitant medication was reported. No adverse effects reported. No product quality complaint (PQC) was reported. The outcome of evens was unknown. No further adverse event information was available. Follow up information (after previous telephone attempt to obtain follow up information which has been unsuccessful) has been received from a nurse concerning VARIVAX (merck) temperature excursion and one patient of unspecified age and gender who was vaccinated with VARIVAX (merck) (injection, strength, dose, frequency, route of administration and indication were not provided) (lot # J012384, exp date: 31-OCT-2015 also reported as 03-OCT-2015) that reached 18.5 F for 10 hours and 44 minutes. This is one of several reports received from the same source. Additional information has been requested.
PATIENT REPORTED SKIN ON FEET AND LEGS STARTED TO PEEL 2-3 WEEKS AFTER INITIAL VACCINE. SHE JUST GOT THE 2ND VACCINE  A FEW DAYS AGO SO IT IS TOO EARLY TO TELL IF IT WILL HAPPEN AGAIN. BUT SHE REPORTS THAT WHEN SHE TOOK OFF THE BANDAID THIS TIME, THE SKIN WAS PEELING
Monday evenig shot, regular bed /sleep cycle.  Tuesday woke up :Tired, less appetite, thirsty.Wednesday  Red Rash around site size of #2 pencil eraser.   Used anti itch cream.  Thursday, rash spread to arms, back, cheest and under breasts and mouth.  Used anti itch cream. Friday:  called Dr. but offices were closed because of ice storm.  Used Zytec, anti ittch cream and Motrin.
Pt recvd 3 doses of Engerix-B & titer report dated 13DEC91 indicated pt did not respond;
Inability to raise arm without incredible pain; Bruising and swelling from breast to shoulder on right side; Bruising and swelling from breast to shoulder on right side; Kidneys sore; Sick to stomach; Headache; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the right arm on 01Apr2021 at 16:00 (at the age of 56-years-old), as a single dose for COVID-19 immunisation. Medical history included COVID-19. Concomitant medications were not reported. The patient previously took flu shot on an unknown date for immunisation and experienced that her body did not tolerate the flu shot. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Apr2021 at 04:00, the patient experienced inability to raise arm without incredible pain, bruising and swelling from breast to shoulder on right side, kidneys were sore, sick to stomach and headaches. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. The clinical outcome of the events inability to raise arm without incredible pain, bruising and swelling from breast to shoulder on right side, kidneys were sore, sick to stomach and headaches were not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
In error, patient was given 1st dose of the Moderna vaccine after having Janssen vaccine on 04/09/2021
Patient felt ok the day of the shot, next day got very sick. Said he felt terrible, felt like the vaccine was going to "do him in." He complained of weakness and shortness of breath. He was dehydrated and worried about his kidney function. Said he had a hard time going to the bathroom with stomach pains. On Mar 31, 2021, said he had fever, but didn't go to doctor. Was taken by ambulance April 3 to ER, admitted that night, transferred to ICU on April 4, on ventilator, proceeded to experience multiple organ failure and died on April 11, 2021
Had bad case of flu within days of getting flu shot; Initial information received on 30-Nov-2020 regarding an unsolicited valid non-serious case received from a patient via social media. This case is linked to case 2020SA346206.  This case involves patient (unknown demographics) who had bad case of flu within days of getting flu shot (influenza) while he/she received vaccine INFLUENZA VACCINE.  The patient's medical history, past medical treatment, vaccination, concomitant medication and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer lot number not reported via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient who had bad case of flu within days of getting flu shot (influenza) unknown latency following the administration of INFLUENZA VACCINE. It was reported that the patient had spoken with others with similar experience.  It was not reported if the patient received a corrective treatment.  The event outcome was unknown.
(L) leg redness, erythema, mildly warm to touch, slightly indurated, no central fluctuance or firmness. Pt not reacting to palpation of erythema.
ED to Hosp-Admission  Discharged 10/26/2021 - 10/28/2021 (2 days)   Sepsis  Acute cystitis without hematuria Mechanical fall COVID-19 infection Type 2 diabetes mellitus Essential hypertension Mixed hyperlipidemia Hypothyroidism Depression with anxiety Overactive bladder Chronic back pain Presenting Problem/History of Present Illness/Reason for Admission Per admission H&P: "The patient is an 77 y.o. female, with history of type 2 diabetes, recurrent UTIs, history of septic shock 2020 due to UTI, essential hypertension, hyperlipidemia, hypothyroidism, ambulatory dysfunction due to back pain, spinal stenosis of lumbar region with multiple lumbar surgeries, CKD stage II, presents to the ED via son after having two nonsyncopal falls at home due to weakness and lightheadedness.  She denies striking her head. Patient notes she had similar symptoms a year ago when she was admitted to the ICU due to septic shock, UTI and bacteremia. She had both initial Covid vaccines as well as a booster without any known sick contacts. In the emergency department, she was found to be Covid positive with abnormal UA, however CTA chest was negative for PE or any other acute changes."   Hospital Course Patient was admitted and started on Rocephin for her presenting UTI along with dexamethasone for her presenting COVID-19 virus infection. With 48 hours of treatment she returned to her baseline level of health. She was evaluated by PT and OT who cleared her for home. She is being discharged in stable condition with VNA.
Client received Flu vaccine on 10/17/2008. He had some tenderness at site after injection, but it went away. Approximately 1 week after the injection he developed a sharp pain in the back of his left upper arm only  when he stretches his arm to put his coat on. Denies pain at any other time. He had been raking leaves and does physical labor at work.He had not taken anything for the pain and had not seen his Doctor.Client was advised to take Tylenol or Advil and notify MD.
Intense chills, fatigue, nausea, muscle and joint pain. Lasted 12 hours
Pt had redness, swelling and tenderness in the arm where she received the vaccine. This lasted several days.
This spontaneous report as received from a medical assistant refers to a 3 year old female patient (currently 7 years old). Medical history and concurrent conditions were not reported. In 2010 the patient was vaccinated with M-M-R II. Dose, route, lot number and expiration date were not reported. No co-suspect and concomitant therapies were reported. Medical assistant reported that the patient received a dose on Measles vaccine (unspecified) and Rubella vaccine (unspecified) at about 1 years old on an unspecified date (approximately in 2008). Patient was not administered a mumps vaccine at about 1 year of age. Patient was then administered M-M-R II on an unspecified date in 2010. Vaccines were administered on a schedule outside of the prescribing information. No adverse events were reported. Additional information has been requested.
Seen in Hospital ER for an itchy maculopapular dermatomal rash T8.
Patient received the vaccine. He stated he felt fine-not dizzy/etc     He stood up and I walked him to the vaccination waiting area. Myself as well as 2 of my technicians checked in on him for  a total of 3 checks. He was waiting for another person to get their vaccination. Upon checking in on the other person (he was still sitting in the waiting area) I asked him how he was feeling. Approximately  25 min had elapsed. He said his throat felt weird like closing. I had him remove his mask immediately. I assisted him to the immunization booth. He was able to walk on his own. I observed him. He said it felt the same maybe a little worse. No other signs of allergic reaction. Technician called 911. He said he was not dizzy and his color was normal. His blood pressure was slightly elevated. He said he had to keep yawning and felt tired and his throat seemed to be getting worse. I administered an epipen and immediately afterwards the paramedics were there. He walked to the stretcher and they took him to the hospital for further evaluation.
About 8 hours after the vaccine, my muscle in the injected arm was getting really sore.  I also started getting a headache.   I was feeling a little tired.   After 24 hours, the muscle in the injected arm was very sore.   It was hard to lift the arm even up to my shoulder.   I had a headache and was fatigued.   By 32 hours after the vaccine, I was starting to feel better.   By 48 hours after the vaccine, I was feeling good.   The sore arm muscle lasted about 72 hours.
Pain worsening at injection site for days after vaccine. Finally went to orthopedist, who said it is  irritation of the nerve. She is currently receiving physical therapy.
Pt. states that after receiving the 1st dose of Moderna 02/05/2021, started experiencing symptoms 02/15/2021 of numbness and tingling in both feet, numbness traveling throughout the legs and upper extremities. 02/21/2021 difficulty walking, Emergency Room visit Medical Center, admitted for Observation x10 days/Non-Conclusive. Discharged with referral to Neuro.
contracted the Delta variant; contracted the Delta variant; sick/a general feeling of illness; fever; aches; head congestion; fatigue; brain fog; This is a spontaneous report from a contactable consumer. A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. It was reported that the consumer had been double vaccinated early in Jan2021 with Pfizer and contracted the Delta variant from the patient who also had the Pfizer. The patient got it in another country. He gave it to the consumer and another 32-year-old woman who was J&J vaccinated. All of them got very sick with fever, aches, head congestion, fatigue, brain fog and a general feeling of illness. The consumer had now lost taste and smell. This had been ongoing for 6 days. Outcome of the events was unknown.  Information about batch/lot number has been requested.
Headaches, periods were very erratic.  She would have them every 14 days @times, and others just spotting. Very bad cramps and periods were heavier after the 1st Gardasil shot. Wasn't her normal spunky and happy self. She was very tired and the last few weeks before she passed away, sheslept alot during the day which she never did. Never had any other problems prior to the Gardasil shots.  She recieved all three shots in the series.  Last shot was 5-2-2007. 2/9/09-autopsy report received-COD-undetermined by autospy and toxicology.3/18/09-records received-well visit C/O contact dermatitis, nasal congestion, itchy sore throat times 2-3days. HPV4 lot#1424 F received 1/3/07 in right deltoid. Lot #0384U received 5/2/07 left deltoid and 12/2/08 lot#0955F left deltoid.
Patient resulted in the ED after experiencing vasovagal syncope following the Moderna vaccination.  Although this was her first dose of the Moderna vaccination, it was reported this has happened before. "She has had this before when she gets upset, freaks out holds her breath and then passes out." Patient improved shortly after admission.
05/07/2003: At 07:00, mom noted right arm swelling, redness, itch and tenderness.  Child was given ibuprofen 1.5 tsp and sent to school.  Child received DTaP to right arm 05/05/2003.
Information has been received from a nurse, referring to an unspecified number of patients of unknown ages and genders. The patients' medical history, concurrent conditions and concomitant therapies were not reported. On an unknown date, the patients were vaccinated with an improperly stored doses of GARDASIL 9 (strength, dose, lot number, expiration date, administration route and anatomical location were not provided) for prophylaxis. No adverse effects were reported. The vaccines had a temperature excursion of 0.7 (1 Celsius (C)) for 180 hours with no previous temperature excursions. Also it was reported that a digital data logger was involved. No product quality complaint (PQC) was involved. This is one of several reports received from the same source. Additional information has been requested.; Sender's Comments: US-009507513-1702USA002225:
shot hurt at time of injection, sore arm, pain increasing by the day, arm became immobile, from shoulder to hand
Developed a massive herpes on her lip within 2-3 days of the vaccine; A large knot on the side of her head for 10 days; Extreme fatigue; Feels like she is coming out of a deep sleep when she wakes up and it lasts all day; Terrible constipation; Nose bleed; Weakness; Achiness in right arm; Having nightmares; Her blood pressure has gone up to the 150's to 170's; This is a spontaneous report from a contactable consumer (patient). A 69-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via unspecified route of administration on 04Jan2021 at single dose for COVID-19 immunisation. The relevant medical history included mono hepatitis (in her 20's which made her liver enzymes go up) and epstein barr titers (high since she had the mono). Concomitant medications were not reported. On an unspecified date in Jan2021, the patient developed a massive herpes on her lip within 2-3 days of the vaccine, a large knot on the side of her head for 10 days, extreme fatigue, feels like she was coming out of a deep sleep when she wakes up and it lasts all day, terrible constipation, nose bleed, weakness and achiness in right arm, having nightmares and her blood pressure has gone up to the 150's to 170's. The patient refused to get the second dose of the Pfizer covid 19 vaccine because of the reaction that she had to the first dose. The patient underwent lab test included blood pressure which showed gone up to the 150's to 170's on an unspecified date in Jan2021. The outcome of the events was unknown.  No follow-up attempts are possible; information about batch/lot number cannot be obtained.
Patient reported localized warmth, lump still present at site of injection (left arm) 7/22 and had been feeling okay prior to that .  Additionally reported that on 7/22 had eaten lunch brought in to the office and in the afternoon started feeling achy.  Continued to feel bad on 7/23 and had diarrhea so she called off from work this day.  On 7/24 had sensation of hot and cold.  Went back to work on 7/26 but felt exhausted so left early and went to ER in the evening.  SARS-COV-2 (COVID-19) antigen test done which resulted as negative (7/26/21).
Symptoms start 10/24/14: sore throat, headache, swollen neck glands, pain in right shoulder/torso. Symptoms subsided 11/25/14.
This spontaneous report was received from a healthcare professional regarding a patient of unknown age and gender. The patient's concurrent conditions, medical history and concomitant medications were not reported. On 25-MAY-2016, the patient was vaccinated with improperly stored dose of ROTATEQ lot # L037921 expiration date: 31-MAY-2017 (dose, strength, and route unknown) (incorrect product storage). The vaccine was exposed to temperature of 33.6 Fahrenheit for 12 hours. Data logger was involved. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Arthritic pain, swollen joint on right hand, pain in both ankles, big toe on right foot and also right elbow pain and swelling is ongoing. I am being treated by a rheumatologist and I am taking RX: Celebrex 200mg 2 X daily.
This case was reported by a healthcare professional, via a GSK representative, and described the occurrence of raised red bump at injection site in an adult subject of unspecified gender who was vaccinated with FLULAVAL (GlaxoSmithKline). On an unspecified date in September 2011 the subject received a dose of FLULAVAL (unknown route, unknown deltoid). On an unspecified date in September 2011, the same week after vaccination with FLULAVAL, the subject experienced raised red bump at injection site. The bump covered most of the deltoid. At the time of reporting the outcome of the event was unspecified. The healthcare professional reported 3 subjects who experienced raised red bump at injection site after vaccination with FLULAVAL. This is case 3 of 3 (see case IDs A0947999A, A0948000A for details of the other reports). The healthcare professional had reported the case to VAERS.
I gave patient only the saline Diluent and not the HIB powder substance with it. No reaction so far in when patient was in office.
A report was received from a health care professional on 12/8/03 concerning 5 children of unspecified sex and aged between 8 months and 3 years of age who inadvertently received Fluvirin on 12/6/03. On 12/6/03, five children inadvertently received Fluvirin. At the time of the report no adverse events had been reported. There was insufficient information to determine the reporter's causality assessment. Update 3/8/04: Follow up information received from a health care professional indicated that a 3.5 year old female vaccinee inadvertently received Fluvirin on 12/6/03. No adverse events have been reported to date. No follow up pending. All information received.
Patient claims that arm is painful and sensitive to touch, attributes that the vaccine is the cause of the pain.
Rash at injection site 8 days following vaccine.  Site became swollen, red and very warm to touch for 72 hours.
Pain in left side of chest, feels like my heart is sore.  I also have less energy, and feel afraid to exercise or push myself to do much physical activity.  I think it's maybe getting slightly better and will clear on it's own.  I've not called my doctor or done anything to treat it other than take it easy.  It hurts more if I cough, clear my throat, or take really deep breaths.    I also remember having this type of pain for a week or two following my second COVID vaccine (also Pfizer, 3/12/21), beginning about a day after I got the vaccine.  When I looked up these symptoms it appears to fit the description of myocarditis, so I wanted to report so it is documented and for my own safety.
There were no adverse reactions. Resident Died, she had a history of issues with her health prior to the vaccine.
Patient said she had a "slow anaphylaxis" reaction over several hours that included tightness in her chest.  She went to a local walk in clinic and the doctor did not agree with her assessment.  The doctor gave her a fluticasone nasal spray and albuterol inhaler.
Severe burning  rash with bumps on shot site that included most of the upper arm..  Severe muscle pain.  Severe fatigue with low grade fever.  The muscle pain lasted for two weeks.  The rash lasted longer, about three weeks. The rash faded over time, not all at once.
Information has been received from a pharmacist concerning an approximately 63 year old female with no allergy to neomycin or gelatin who on 04-APR-2008 was vaccinated subcutaneously with one dose of ZOSTAVAX (Oka/Merck) (Lot #659761/0157X).  There was no concomitant medication.  On an unspecified date following vaccination the patient developed achiness in the upper arm about 8 inches surrounding the injection site.  No change in temperature or color noted.  The patient's achiness surrounding the injection site persisted.  The patient sought medical attention by speaking with the pharmacist.  Additional information has been requested.
Patient's mom stated patient had a fever of 103 the night of 10/12/15. Patient came in for triage - temperature of 99.1. PA-C recommended BENADRYL as needed. Patient has redness and induration to right arm.
Pt developed raised, red area that was painful to touch. Able to walk without pain or difficulty. Instructed mom to seek PCP and advise as well as instructing mom to use Motrin every 6 hours and ice.